ENTITY
CSL Ltd

CSL Ltd (CSL AU)

227
Analysis
Health Care • Australia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bearish•JB Hi-Fi Ltd
•01 Sep 2023 07:10

MVIS Australia Equal Weight Index Rebalance Preview: Potential Deletes & Capping Increase Turnover

There could be 2 index deletes in Sep. There are 3 stocks that are close to the deletion threshold. There are unlikely to be any adds. There will...

Logo
832 Views
Share
•20 Aug 2023 07:19

Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
681 Views
Share
bearish•Charter Hall
•14 Aug 2023 05:12

MVIS Australia Equal Weight Index Rebalance Preview: Deletes, Close Deletes, Capping Changes

With a couple of weeks to review cutoff, there are two stocks in deletion zone and another two that are close to the deletion zone. Most likely, no...

Logo
605 Views
Share
•04 Aug 2023 06:00

ASX Short Interest Weekly (Jul 28th): Woodside Energy, NAB, Macquarie, BHP, CSL, Northern Star Re

We estimate the ASX short interests to be USD 16.2bn and highlight short interest changes in Woodside Energy, NAB, Macquarie, BHP, CSL, Northern...

Logo
580 Views
Share
•20 Jul 2023 16:58

ASX Short Interest Weekly (Jul 14th): Fortescue Metals, BHP, Lynas Rare Earth, Suncorp, Woolworths

We analyzed ASX short interest report for the past week and highlight short interest changes in Fortescue Metals, BHP, Lynas Rare Earth, Suncorp,...

Logo
769 Views
Share
x